bioRxivSystems BiologyPreprint
Evaluating Study Design Rigor in Preclinical Cardiovascular Research: A Replication Study
Isaiah C. JimeneziD, Gabrielle C. Montenegro, Keyana ZahiriiD, Damini Nareshkumar Patel, Adrienne L. MuelleriD
Abstract
BackgroundMethodological rigor remains a priority in preclinical cardiovascular research to ensure experimental reproducibility and high-quality research. Limited reproducibility diminishes the translation of preclinical discoveries into medical practice. In addition, lack of reproducibility fosters uncertainty in the publics acceptance of reported research results. MethodsWe evaluated the reporting of methodological practices in preclinical cardiovascular research studies published in leading scientific journals by screening articles for the inclusion of the following study design elements (SDEs): considering sex as a biological variable, randomization, blinding, and sample size power estimation. We screened for these SDEs across articles regarding preclinical cardiovascular research studies published between 2011 and 2021. We replicated and extended a study published in 2017 by Ramirez et al. We hypothesized a higher SDE inclusion across preclinical studies over time, that preclinical studies that include human and animal substudies within the same study will exhibit greater SDE inclusion than animal-only preclinical studies, and that a difference exists in SDE usage between large and small animal models. ResultsSDE inclusion was low; with 15.2% of animal-only studies including both sexes as a biological variable, 30.4% including randomization, 32.1% including blinding, and 8.2% including sample size estimation. The incorporation of SDEs did not significantly increase over the ten-year timeframe in the screened articles. Randomization and sample size estimation differed significantly between animal and human substudies (corrected p=1.85e-05 and corrected p=3.81e-07, respectively.) ConclusionsEvidence of methodological rigor varies depending on the study type and model organisms used. From 2011-2021, SDE reporting within preclinical studies has not increased, suggesting more work is needed to foster the inclusion of rigorous study design elements in cardiovascular research.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Accessibility and Reproducible Research Practices in Cardiovascular Literature
G. Heckerman, E. Tzng, … A. Mueller·bioRxiv·Jul 6, 2022
- Reporting and justification of sample size in translational chronic variable stress procedures: A systematic review
Crispin Y. Jordan, Nicola Romanò, John R. W. Menzies·Experimental PhysiologyPeer-reviewed·Jul 9, 2025
- Statistics in biology: a survey of the three major multidisciplinary journals.
Jean‐Xavier Mazoit·bioRxiv·Feb 4, 2025
- Researchers' perspectives on preregistration in animal research
Cristina Priboi, Boris Mayer, … Hanno Würbel·bioRxiv·Nov 7, 2025
- Funders' expectations for open science in cardiovascular research: A Scoping review of the largest cardiovascular research funders
Anna Catharina Vieira Armond, AlMamoune Alaoui, … Kelly Denise Cobey·Journal of the American Heart AssociationPeer-reviewed·May 6, 2026
- A Reaction Norm Perspective on Reproducibility
Bernhard Voelkl, Hanno Würbel·Theory in BiosciencesPeer-reviewed·Mar 25, 2021